Literature DB >> 26608797

Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway.

Xiaojuan Wu1, Limin Sun2, Xiao Wang1, Peng Su1, Zhishuang Li1, Chunyan Zhang1, Yan Wang1, Peng Gao3, Rong Ma4.   

Abstract

Invasive breast cancer is the most common type of malignancy in women worldwide. However, the mechanism responsible for breast cancer metastasis is still unclear and needs further illustration. It has been proven that matrix metallopeptidase 9 (MMP-9) promotes metastasis of the cancer cells. However, the interaction between mPRα and MMP-9 has not been studied. Therefore, in the present research, the effect of MMP-9 on the malignant progression of invasive breast cancer promoted by membrane progesterone receptorα (mPRα) was investigated. The results showed that the protein expression of mPRα, p-Akt and MMP-9 increased in the cancerous tissues compared to that of the noncancerous breast tissue. Furthermore, a positive correlation was found between mPRα and C-erbB-2, as well as the number of involved local lymph nodes. On the other hand, a negative correlation was observed between mPRα and estrogen receptors (ER) along with progesterone receptors (PR). Similarly, a positive association was found between MMP-9 and the number of involved local lymph nodes. Besides, the high expression of MMP-9 also had a positive correlation with the tumor size. However, the high level of MMP-9 had a negative correlation with ER and PR. In addition, there was a positive correlation between mPRα and p-Akt together with MMP-9. The results confirm that mPRα was a major marker of harmful prognosis and it promoted the expression of MMP-9 during invasion to the local lymph nodes through the pathway of PI3K/Akt. The present study provided a novel therapeutic strategy to inhibit breast cancer growth by preventing mPRα signaling pathway.

Entities:  

Keywords:  Invasive breast cancer; MMP-9; Metastasis; mPRα; p-Akt

Mesh:

Substances:

Year:  2015        PMID: 26608797     DOI: 10.1007/s12253-015-0023-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

1.  Metalloregulation of yeast membrane steroid receptor homologs.

Authors:  Thomas J Lyons; Nancy Y Villa; Lisa M Regalla; Brian R Kupchak; Anna Vagstad; David J Eide
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-01       Impact factor: 11.205

Review 2.  Genes related to estrogen action in reproduction and breast cancer.

Authors:  Aninda Basu; Brian G Rowan
Journal:  Front Biosci       Date:  2005-09-01

3.  Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor.

Authors:  Yong Zhu; Jason Bond; Peter Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 4.  Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer.

Authors:  Gayathri Nagaraj; Cynthia Ma
Journal:  Breast Cancer Res Treat       Date:  2015-03-12       Impact factor: 4.872

5.  Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes.

Authors:  Yong Zhu; Charles D Rice; Yefei Pang; Margaret Pace; Peter Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

6.  Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.

Authors:  Romina P Carnevale; Cecilia J Proietti; Mariana Salatino; Alejandro Urtreger; Guillermo Peluffo; Dean P Edwards; Viroj Boonyaratanakornkit; Eduardo H Charreau; Elisa Bal de Kier Joffé; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Endocrinol       Date:  2007-04-17

Review 7.  HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.

Authors:  M L'Hermite
Journal:  Climacteric       Date:  2013-08       Impact factor: 3.005

8.  Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.

Authors:  Asif Loya; Merih Guray; Bryan T Hennessy; Lavinia P Middleton; Thomas A Buchholz; Vicente Valero; Aysegul A Sahin
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

Review 9.  Tumor endothelium is characterized by a matrix remodeling signature.

Authors:  Judy R van Beijnum; Kjell Petersen; Arjan W Griffioen
Journal:  Front Biosci (Schol Ed)       Date:  2009-06-01

10.  Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.

Authors:  Nermeen Salah Youssef; Sarah Adel Hakim
Journal:  Diagn Pathol       Date:  2014-07-04       Impact factor: 2.644

View more
  13 in total

1.  Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progression.

Authors:  Yan Mei; Jun-Ping Yang; Yan-Hong Lang; Li-Xia Peng; Ming-Ming Yang; Qing Liu; Dong-Fang Meng; Li-Sheng Zheng; Yuan-Yuan Qiang; Liang Xu; Chang-Zhi Li; Wen-Wen Wei; Ting Niu; Xing-Si Peng; Qin Yang; Fen Lin; Hao Hu; Hong-Fa Xu; Bi-Jun Huang; Li-Jing Wang; Chao-Nan Qian
Journal:  Cell Cycle       Date:  2018-05-31       Impact factor: 4.534

Review 2.  The Interface of Nuclear and Membrane Steroid Signaling.

Authors:  Lindsey S Treviño; Daniel A Gorelick
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

3.  Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway.

Authors:  Lu Gan; Zhu Qiu; Jing Huang; Yunhai Li; Hongyan Huang; Tingxiu Xiang; Jingyuan Wan; Tianli Hui; Yong Lin; Hongzhong Li; Guosheng Ren
Journal:  Int J Biol Sci       Date:  2016-11-26       Impact factor: 6.580

4.  A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast Cancer

Authors:  Xianhe Xie; Yanfen Hu; Chao Jing; Shuimei Luo; Yunfu Lv; Haitao Yang; Lina Li; Huijuan Chen; Wanzun Lin; Weili Zheng
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

5.  Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction network.

Authors:  Xinhua Chen; Zhe Pei; Hao Peng; Zhihong Zheng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 6.  Differential Impact of Flavonoids on Redox Modulation, Bioenergetics, and Cell Signaling in Normal and Tumor Cells: A Comprehensive Review.

Authors:  Asimina Kerimi; Gary Williamson
Journal:  Antioxid Redox Signal       Date:  2017-09-28       Impact factor: 8.401

7.  Antitumor activities of Aspiletrein A, a steroidal saponin from Aspidistra letreae, on non-small cell lung cancer cells.

Authors:  Hien Minh Nguyen; Hoai Thi Nguyen; Suthasinee Seephan; Hang Bich Do; Huy Truong Nguyen; Duc Viet Ho; Varisa Pongrakhananon
Journal:  BMC Complement Med Ther       Date:  2021-03-09

8.  Rapamycin Antagonizes BCRP-Mediated Drug Resistance Through the PI3K/Akt/mTOR Signaling Pathway in mPRα-Positive Breast Cancer.

Authors:  Jing Zhang; Jing Hu; Weiwei Li; Chunyan Zhang; Peng Su; Yan Wang; Wei Sun; Xiao Wang; Li Li; Xiaojuan Wu
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

Review 9.  Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers.

Authors:  Mirco Masi; Marco Racchi; Cristina Travelli; Emanuela Corsini; Erica Buoso
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

10.  Guizhi Fuling Decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS2 technology and systems pharmacology.

Authors:  Yifei Dai; Weijie Qiang; Xiankuo Yu; Siwei Cai; Kequan Lin; Lan Xie; Xun Lan; Dong Wang
Journal:  Comput Struct Biotechnol J       Date:  2020-05-18       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.